Peak Bio, Inc. (PKBO)
Data as of , from SEC Form 4 filings.
See up to 3 months of PKBO. The 7-day demo opens the 1M and 3M ranges and puts PKBO on your watchlist.
Start 7-day demoLatest PKBO insider trades
About Peak Bio, Inc. (PKBO)
The SEC lists Peak Bio, Inc. under CIK 0001834645, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
PKBO Form 4 activity by transaction type, last 90 days
No Form 4 activity for PKBO in the last 90 days.
PKBO insider transactions (Form 4)
214 Form 4 filings on record, the earliest from Nov 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| SBI INVESTMENT KOREA CO., LTD. | Other | Common Stock | 83,800 | $0.00 | - | |
| SBI INVESTMENT KOREA CO., LTD. | Derivative | Common Stock | 3,621,489 | - | - | |
| Sandip I. Patel | Other | Common Stock | 763,316 | - | - | |
| Sandip I. Patel | Derivative | Common Stock | 763,316 | - | - | |
| Sandip I. Patel | Derivative | Common Stock | 67,735 | - | - | |
| Sandip I. Patel | Derivative | Common Stock | 68,891 | - | - | |
| Sandip I. Patel | Derivative | Common Stock | 47,364 | - | - | |
| Sandip I. Patel | Other | Convertible Notes | 0 | - | - | |
| Sandip I. Patel | Derivative | Stock Option (Right to Buy) | 400,000 | $0.00 | - | |
| James R. Neal | Other | Common Stock | 37,850 | - | - | |
| James R. Neal | Derivative | Common Stock | 37,850 | - | - | |
| James R. Neal | Other | Convertible Notes | 0 | - | - | |
| James R. Neal | Derivative | Warrant (Right to Purchase) | 33,340 | - | - | |
| James R. Neal | Derivative | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Hoyoung Huh | Other | Common Stock | 4,574,661 | - | - | |
| Hoyoung Huh | Derivative | Common Stock | 4,574,661 | - | - | |
| Hoyoung Huh | Derivative | Common Stock | 8,382,742 | - | - | |
| Hoyoung Huh | Derivative | Common Stock | 372,940 | - | - | |
| Hoyoung Huh | Other | Convertible Notes | 0 | - | - | |
| Hoyoung Huh | Derivative | Warrant (Right to Purchase) | 176,292 | - | - | |
| Hoyoung Huh | Derivative | Stock Option (Right to Buy) | 1,200,000 | $0.00 | - |
PKBO insider trading FAQ
What is the latest insider trade for PKBO?
Peak Bio, Inc. (PKBO) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-04. The full record for PKBO runs to 4 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PKBO stock?
No insider purchases of PKBO were filed in the last 90 days.
How many insiders are selling PKBO stock?
No insider sales of PKBO were filed in the last 90 days.
Where can I see PKBO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PKBO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
4The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - SBI INVESTMENT KOREA CO., LTD. view on EDGAR
- - Sandip I. Patel view on EDGAR
- - James R. Neal view on EDGAR
- - Hoyoung Huh view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PKBO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PKBO with a 7-day demo
- PKBO on your watchlist
- Every PKBO Form 4 filing on record
- Up to 3 months of PKBO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
